PHARMIDEA SIA
PolandAll drugs from this manufacturer
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the strength and frequency of uterine contractions.
Dosage form: solution for injection
Active substance Dosage atosiban 6.75 mg/0.9 ml ATC: G02CX01
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the strength and frequency of uterine contractions.
Dosage form: solution for infusion, concentrate
Active substance Dosage atosiban 37.5 mg/5 ml ATC: G02CX01
-
The medicinal product is used to treat multiple myeloma (a type of bone marrow cancer) in adults over 18 years of age and to treat mantle cell lymphoma (a type of cancer that affects the lymph nodes).
Dosage form: powder for preparation of injection solution
Active substance Dosage bortezomib 3.5 mg ATC: L01XG01
-
The medicine is used in women immediately after childbirth to help the uterus contract sufficiently quickly. This reduces the risk of excessive postpartum bleeding.
Dosage form: solution for injection
Active substance Dosage carbetocin 100 mcg/ml ATC: H01BB03
-
The medicine is used in adults as an additional, short-term treatment for acute decompensated severe chronic heart failure. It helps increase the heart's pumping strength, facilitates oxygen flow, and helps relieve shortness of breath.
Dosage form: solution for infusion, concentrate
Active substance Dosage levosimendan 2.5 mg/ml ATC: C01CX08